Celcuity Inc (CELC) ニュース

Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]

Form 10-Q - Quarterly report [Sections 13 or 15(d)]

Form 8-K - Current report

Celcuity Inc. Reports Third Quarter Financial Results and Provides Corporate Update

The PIK3CA wild-type cohort of the Phase 3 VIKTORIA-1 trial is 100% enrolled; expect to report topline data for...

Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]

Celcuity Inc. To Present at Upcoming Stifel and Jefferies Investor Conferences

MINNEAPOLIS, Nov. 12, 2024 (GLOBE NEWSWIRE) -- Celcuity Inc. (Nasdaq: CELC), a clinical-stage biotechnology...

Celcuity Inc. Schedules Release of Third Quarter 2024 Financial Results and Webcast/Conference Call

MINNEAPOLIS, Nov. 07, 2024 (GLOBE NEWSWIRE) -- Celcuity Inc. (Nasdaq: CELC), a clinical-stage biotechnology...

Form 4 - Statement of changes in beneficial ownership of securities

Form D/A - Notice of Exempt Offering of Securities: [Amend]

Form 8-K - Current report

Form S-3 - Registration statement under Securities Act of 1933

Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material

Form DEF 14A - Other definitive proxy statements

Form 4 - Statement of changes in beneficial ownership of securities

Form 4/A - Statement of changes in beneficial ownership of securities: [Amend]